Access To Medicine

Evaluating the safety profile of mifepristone

April 22, 2024 - Mifepristone, commonly known as the abortion pill, is a medication used primarily for medically induced abortions as well as the management of Cushing's syndrome and uterine leiomyomas. Since its approval in 2000, mifepristone has been the subject of extensive research and scrutiny, although it has a favorable safety profile.  The safety evaluation of mifepristone has gained...

Read More


More Articles

Comparing Merck and Pfizer’s 2022 ESG Ratings

by Hayden Schmidt

Environmental, social, and governance assessments, commonly called ESG scores, are emerging metrics that are beginning to shape how pharmaceutical companies do business. MSCI Inc., an American finance...

Canadian Province Restricts Ozempic Sales to United States Citizens

by Veronica Salib

On March 28, 2023, British Columbia (BC), a Canadian Province, announced it would restrict Ozempic sales to United States citizens. The release from government officials notes that US citizens crossing...

Fundamentals of the Pharmaceutical Supply Chain

by Alivia Kaylor

The pharmaceutical supply chain poses risks and challenges to both providers and consumers. But in the context of a health-conscious society, managing pharmaceutical supply chains presents several...

The Policy Problem Behind Adderall’s Pharmaceutical Supply Chain Crisis

by Hayden Schmidt

Attention deficit/hyperactivity disorder (ADHD) is a prevalent mental health condition described as a generalizable inability to pay attention or control impulsive behavior and a tendency to be overactive. The Centers for Disease Control...

California Partners with Civica to Make Affordable Insulin Available

by Veronica Salib

One day into his second term, Governor Gavin Newsom of California has announced a partnership between CalRx, a California Department of Healthcare Services program, and Civica, a healthcare nonprofit,...

Behind Walgreens’ Decision to Forgo Abortion Pill Distribution in Some States

by Hayden Schmidt

Last week, Walgreens announced that it would no longer distribute abortion pills in 20 states across the US following legal warnings made by the attorneys general of those states. Specifically,...

The Importance of Delaying the Onset of Type 1 Diabetes with New Treatment

by Alivia Kaylor

With a new FDA-approved immunotherapy treatment designed to delay the onset of type 1 diabetes (T1D), patients — 8 years or older — can enjoy more years without the physical and financial burdens of living with...

FDA Expands Access to Abortion Pills in Retail Pharmacies

by Veronica Salib

In a step towards widening access, the FDA made a regulatory change, allowing the abortion pill, mifepristone, to be distributed by retail pharmacies with a valid prescription. Mifepristone is one...

Pfizer Invests $750M in Michigan Pharmaceutical Manufacturing Expansion

by Hayden Schmidt

Pfizer is investing $750 million to expand its primary manufacturing facility in Kalamazoo, Michigan. The expansion will allow the pharmaceutical company to increase the production of vaccines and...

How Can Providers Help Patients Navigate Increased Drug Costs?

by Veronica Salib

In a recent press release, GoodRx, a digital healthcare platform, launched Provider Mode. Provider Mode is a new experience that is specifically targeted to healthcare professionals (HCPs). PharmaNewsIntelligence interviewed Preeti Parikh,...

Nearly 13% of Oral Anticancer Prescriptions Are Not Received

by Veronica Salib

The financial burden associated with cancer treatment and recovery is significant. Many patients struggle to obtain medicines and continued care. According to a recent study published in JAMA Network...

How A Prescription Drug Becomes Available Over the Counter

by Veronica Salib

The FDA approval process is complex and involves multiple steps. Understanding how a prescription drug becomes available over the counter (OTC) is essential for healthcare professionals, members of the pharmaceutical industry, and...

McKesson Plans to Acquire Rx Savings Solutions

by Veronica Salib

On Monday, September 19, McKesson announced that it had signed an agreement with Rx Savings Solutions. This agreement focuses on the company’s plans to acquire Rx Savings Solutions to advance the...

Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge

by Hayden Schmidt

Pfizer is back at it with another acquisition, this time scooping up the rare disease pharmaceutical company Global Blood Therapeutics for $5.4 billion in cash. Pfizer’s acquisition will cede...

Aid Access Discusses Making Abortion Pill Available as Contraception

by Veronica Salib

In an interview with Democracy Now, Rebecca Gomperts, MD, mentioned plans to make mifepristone, the abortion pill, available as a weekly or emergency contraceptive. Gomperts is the founder of Aid...

FDA Expands EUA to Allow Pharmacists to Prescribe Paxlovid

by Veronica Salib

Recently, the FDA expanded its emergency use authorization (EUA) for Paxlovid, an oral antiviral medication. This expansion permits pharmacists to prescribe this antiviral medication to patients...

FDA Approves First Drug for Chronic Disease Eosinophilic Esophagitis

by Hayden Schmidt

Sanofi’s Dupixent received FDA approval for use in people suffering from eosinophilic esophagitis (EoE) after a double-blind, placebo-controlled trial proved the drug effectively reduces...

Pfizer Acquires Biohaven Pharmaceutical for $11.6 Billion in Cash

by Hayden Schmidt

Pfizer Inc. and Biohaven Pharmaceutical announced that Pfizer will acquire Biohaven for $11.6 billion in cash after years of collaborative drug development, improving access to medicine used to treat...

FDA Approves Eli Lilly and Company’s Type 2 Diabetes Injectable

by Samantha McGrail

FDA recently approved Eli Lilly and Company’s Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes as an addition to diet and...

Recent Articles